Cardiac Inflammation Research Group
11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Circulating soluble LOX-1 and patient prognosis after an acute coronary syndrome
(2025) In Heart
- Contribution to journal › Article
-
Mark
IFNγ+ NKT-like cells are associated with increased incidence of atrial fibrillation in elderly women
- Contribution to journal › Article
-
Mark
Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis
- Contribution to journal › Article
-
Mark
Development of novel neutralizing single-chain fragment variable antibodies against S100A8
- Contribution to journal › Article
- 2024
-
Mark
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population
- Contribution to journal › Article
-
Mark
Increasing plasma calprotectin (S100A8/A9) is associated with 12-month mortality and unfavourable functional outcome in critically ill COVID-19 patients
- Contribution to journal › Article
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
- Contribution to journal › Article
-
Mark
A study of size-selective renal elimination using a novel human model
- Contribution to journal › Article
-
Mark
Special Issue “COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies”
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reply to “Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients”
- Contribution to journal › Letter
